Home › Funds › ARCH Venture Management, LLC › BEAM
ARCH Venture Management, LLC position in BEAM
BEAM THERAPEUTICS INC · Health Care
ARCH Venture Management, LLC reported holding 4,540,132 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$111.0M, representing 6.88% of its reported portfolio and ranking #9 among its reported holdings. ARCH Venture Management, LLC has disclosed BEAM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How ARCH Venture Management, LLC's BEAM position evolved
ARCH Venture Management, LLC first disclosed a stake in BEAM in Q2 2024 at 5,443,039 shares (US$127.5M). The position peaked in Q2 2026 at 4,540,132 shares, worth US$155.8M. Across 10 filings, ARCH Venture Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 4,540,132 shares valued at US$111.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 5.44M | $127.53M | New |
| Q3 2024 | 4.83M | $118.45M | Reduce |
| Q4 2024 | 4.54M | $112.60M | Reduce |
| Q1 2025 | 4.54M | $88.67M | Hold |
| Q2 2025 | 4.54M | $77.23M | Hold |
| Q3 2025 | 4.54M | $110.19M | Hold |
| Q4 2025 | 4.54M | $125.85M | Hold |
| Q1 2026 | 4.54M | $108.19M | Hold |
| Q2 2026 | 4.54M | $155.77M | Hold |
| Q3 2026 | 4.54M | $111.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), ARK Invest (US$288.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$251.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 11.81M sh · $288.64M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.28M sh · $251.26M · Q3 2026
- Kynam Capital Management, LP 3.93M sh · $96.18M · Q3 2026
- Amova Asset Management Americas, Inc. 3.35M sh · $81.76M · Q3 2026
- Casdin Capital 1.50M sh · $36.67M · Q3 2026
- Redmile Group, LLC 1.06M sh · $25.96M · Q3 2026
More on ARCH Venture Management, LLC
FAQ
How long has ARCH Venture Management, LLC held BEAM?
ARCH Venture Management, LLC has disclosed BEAM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is ARCH Venture Management, LLC's current position in BEAM?
As of Q3 2026, ARCH Venture Management, LLC holds 4.54M shares of BEAM (BEAM THERAPEUTICS INC), valued at $111.01M, representing 6.88% of its reported portfolio and ranking #9.
Has ARCH Venture Management, LLC been buying or selling BEAM?
In the latest 13F filing (Q3 2026), ARCH Venture Management, LLC held unchanged its position in BEAM. The position peaked in Q2 2026 at 4.54M shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include Farallon Capital Management, ARK Invest, FARALLON CAPITAL MANAGEMENT, L.L.C., among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.